Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

Interview with Niklas Kouparanis, founder and CEO of Europe’s largest medical cannabis digital health company, Bloomwell

Germany’s medical cannabis market has been booming since it was removed from the list of controlled narcotic substances in 2024, which made prescribing it much easier. Now as many as one million Germans are being prescribed cannabis, according to the most often cited figure by those in the industry. The majority of these prescriptions are being handed out by digital health companies specialising in cannabis. The largest of these companies is Bloomwell, who HBI sat down with last week at Cannabis Europa (a conference focused on medicinal cannabis).
June 4, 2026

France’s obesity drug reimbursement plan could reshape insurers’ role in care

France will begin reimbursing anti-obesity medicines from mid-June 2026, becoming the first EU country to introduce public coverage for treatments including Wegovy and Mounjaro, produced by Danish pharma giant Novo Nordisk and American pharmaceutical company Eli Lilly respectively. The policy is intended to prioritise high-risk patients rather than general weight management. Access will be limited to patients with severe obesity, defined as a BMI of at least 40, or at least 35 where accompanied by conditions such as type 2 diabetes or cardiovascular disease.
June 4, 2026

CordenPharma acquires AmbioPharm

CordenPharma, a CDMO backed by private equity firm Astorg, has acquired AmbioPharm, a US-headquartered peptide CDMO, from private equity firm Carlyle. 
June 4, 2026

What does the £900m NHS AI framework mean for UK healthcare? 

A new major UK-wide framework for Healthcare AI Solutions, with a maximum spend ceiling of £750–900 million (~€867–1,040 mn) to be spent over eight years (2027–2035), has been launched. What does it mean for providers and investors?
June 4, 2026

Clue becomes first insurance-backed menstrual tracking app

Period and cycle tracking platform Clue has become the first women’s health app to be covered by health insurance following a partnership with German private insurer SDK (Süddeutsche Krankenversicherung). Under the agreement, thousands of SDK policyholders, along with around 1,600 employees across SDK and Stuttgarter Lebensversicherung, will receive access to Clue Plus at no extra cost. Members can activate the service via a dedicated link and code, while existing users will keep their accounts unchanged.
June 4, 2026
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us